These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 29217066)

  • 21. [Hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease) as an example of a rare disease relevant for oto-rhino-laryngology].
    Geisthoff UW; Maune S; Schneider G
    Laryngorhinootologie; 2011 Apr; 90(4):230-42; quiz 243-4. PubMed ID: 21523625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hereditary hemorrhagic telangiectasia: an overview of diagnosis and management in the molecular era for clinicians.
    Bayrak-Toydemir P; Mao R; Lewin S; McDonald J
    Genet Med; 2004; 6(4):175-91. PubMed ID: 15266205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemorrhagic pericardial effusion causing pericardial tamponade in hereditary hemorrhagic telangiectasia.
    Kanna B; Das B
    Am J Med Sci; 2004 Mar; 327(3):149-51. PubMed ID: 15090753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist's perspective.
    Kritharis A; Al-Samkari H; Kuter DJ
    Haematologica; 2018 Sep; 103(9):1433-1443. PubMed ID: 29794143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hereditary hemorrhagic teleangiectasia (Rendu-Osler-Weber disease).
    Sabbà C; Pasculli G; Cirulli A; Gallitelli M; Virgilio G; Resta F; Guastamacchia E; Palasciano G
    Minerva Cardioangiol; 2002 Jun; 50(3):221-38. PubMed ID: 12107402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complications from office sclerotherapy for epistaxis due to hereditary hemorrhagic telangiectasia (HHT or Osler-Weber-Rendu).
    Hanks JE; Hunter D; Goding GS; Boyer HC
    Int Forum Allergy Rhinol; 2014 May; 4(5):422-7. PubMed ID: 24431220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hereditary hemorrhagic telangiectasia: an update on clinical manifestations and diagnostic measures.
    Sadick H; Sadick M; Götte K; Naim R; Riedel F; Bran G; Hörmann K
    Wien Klin Wochenschr; 2006 Mar; 118(3-4):72-80. PubMed ID: 16703249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Rendu-Osler disease: clinical and molecular update].
    Bailly S; Dupuis-Girod S; Plauchu H
    Med Sci (Paris); 2010 Oct; 26(10):855-60. PubMed ID: 20929677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bevacizumab: a new success in hereditary hemorrhagic telangiectasia].
    Bennesser Alaoui H; Lehraiki M; Hamaz S; El Attar N; Fakhreddine N; Serraj K
    Rev Med Interne; 2015 Sep; 36(9):623-5. PubMed ID: 25595875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pulmonary manifestations of hereditary hemorrhagic telangiectasia].
    Cottin V; Blanchet AS; Cordier JF
    Rev Mal Respir; 2006 Apr; 23 Suppl 2():4S53-4S66. PubMed ID: 16733401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Rendu-Osler-Weber disease (hereditary hemorrhagic telangiectasia). Report of 30 cases].
    Morales Angulo C; Megía López R; del Valle Zapico A; Mazón Gutiérrez A; García Mantilla J; Rama Quintela JJ
    Acta Otorrinolaringol Esp; 1997; 48(8):625-9. PubMed ID: 9528135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anesthetic considerations for the patient with hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome).
    Peiffer KM
    AANA J; 2009 Apr; 77(2):115-8. PubMed ID: 19388506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hereditary hemorrhagic telangiectasia.
    Peng YF; Chen LK; Chou YH; Chang FC; Hwang SJ
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Dec; 65(12):614-8. PubMed ID: 12636208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anesthetic management of a patient with hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Case report.
    Goulart AP; Moro ET; Guasti VM; Colares RF
    Rev Bras Anestesiol; 2009; 59(1):74-8. PubMed ID: 19374218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of cutaneous and mucosal telangiectases in hereditary hemorrhagic telangiectasia: Report of three cases.
    Fernández-Jorge B; Del Pozo Losada J; Paradela S; Martínez-González C; Fonseca E
    J Cosmet Laser Ther; 2007 Mar; 9(1):29-33. PubMed ID: 17506138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Screening for systemic manifestations of vascular malformations in patients with hereditary haemorrhagic telangiectasia (Osler disease)].
    Cerra Pohl A; Werner JA; Folz BJ
    Acta Otorrinolaringol Esp; 2008 Nov; 59(9):463-8. PubMed ID: 19080778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutation analysis in Norwegian families with hereditary hemorrhagic telangiectasia: founder mutations in ACVRL1.
    Heimdal K; Dalhus B; Rødningen OK; Kroken M; Eiklid K; Dheyauldeen S; Røysland T; Andersen R; Kulseth MA
    Clin Genet; 2016 Feb; 89(2):182-6. PubMed ID: 25970827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anesthetic Considerations for a Patient With Hereditary Hemorrhagic Telangiectasia (Osler-Weber-Rendu Syndrome) Undergoing a Five-Box Thoracoscopic Maze Procedure for Atrial Fibrillation.
    Robinson D; Rogers B; Kapoor R; Swan J; Speas G; Gutmann R
    J Investig Med High Impact Case Rep; 2014; 2(4):2324709614553669. PubMed ID: 26425624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pulmonary arterial hypertension in patients with hereditary hemorrhagic telangiectasia (Osler-Rendu disease)].
    Tepliuk TB; Soboleva SS; Tokarev IuN; Ol'binskaia LI
    Ter Arkh; 1986; 58(4):81-3. PubMed ID: 3715761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Epistaxis in Rendu-Osler-Weber disease treated with selective embolization--case report].
    Jarzabek M; Trojanowski P; Szajner M; Pyra K; Sojka M; Szczerbo-Trojanowska M
    Przegl Lek; 2012; 69(7):317-9. PubMed ID: 23276024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.